SUN PHARMA (SMPQY) share price has Zoomed 6% and is presently trading at Rs 494. Meanwhile, the BSE HEALTHCARE Index is at 13,269 (Up 1.7%).

Among the top Gainers in the BSE HEALTHCARE Index today is SUN PHARMA (up 5.57%).

ERIS LIFESCIENCES LIMITED (down 0.03%) and FORTIS HEALTHCARE (down 0.10%) are among the top losers today.

Over the last one year, SUN PHARMA has moved down from Rs 592 to Rs 494, registering a loss of Rs 97 (down 16.77%)

On the other hand, the BSE HEALTHCARE has moved down from 13,695 to 13,269, loss of 426 points (down 3.14%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were BIOCON LTD (up 111.99%), DIVIS LABORATORIES (up 105.47%) and ABBOTT INDIA (up 61.79%).

What About the Benchmark Indices?

The BSE Sensex is at 35,101 (up 0.49%).

The top gainers among the BSE Sensex stocks today are SUN PHARMA (up 5.57%), GAIL (up 2.03%) and BHEL (up 1.73%). Other gainers include SBI (up 1.50%) and TATA STEEL (up 1.15%). The most traded stocks in the BSE Sensex are SUN PHARMA and SBI.

In the meantime, NSE Nifty is at 10,673 (up 0.58%). SUN PHARMA (up 6.55%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 30,750 to 35,101, registering a gain of 4,351 points (up 14.13%).

SUN PHARMA Financial Update...

SUN PHARMA net profit grew 23.1% YoY to Rs 4 billion for the quarter ended December 2017, compared to a profit of Rs 17 billion a year ago. Net Sales rose 84.1% to Rs 66.5 billion during the period as against Rs 79.1 billion in October-December 2016.

For the year ended March 2017, SUN PHARMA reported 123.6% increase in net profit to Rs 78.4 billion compared to net profit of Rs 63.4 billion during FY16.

Revenue of the company grew 110.9% to Rs 316 billion during FY17.

The current Price to earnings ratio of SUN PHARMA, based on rolling 12 month earnings, stands at 42.3x.